INDIANAPOLIS, Sept. 13 /PRNewswire/ -- Roche Diagnostics today announced the U.S. launch of the cobas c 111 system, a clinical chemistry analyzer designed specifically for low- to medium-volume laboratories. The compact system utilizes the same components and reagents as its larger, central-lab COBAS Integra siblings, enabling smaller labs to benefit from equivalent performance and quality results.
(Photo: http://www.newscom.com/cgi-bin/prnh/20070913/CLTH028 )
“This is the first new automated clinical analyzer designed specifically for the lower-volume lab segment in years,” says Ken Levy, Director of Strategic Business Development for Roche Diagnostics. “The cobas c 111 system utilizes the same optics, reagents, cuvettes and calibrators as the larger COBAS Integra systems, allowing labs with low to medium volumes to produce core-lab quality results quickly and conveniently. With the cobas c 111 analyzer in the STAT or outpatient lab and COBAS Integra systems in the central lab, Integrated Health Networks are able to standardize results and quality throughout their network.”
Featuring next-generation technology, the automated cobas c 111 system is easy to use and maintain, and launches with a broad test menu. The analyzer can run up to 80 chemistry and 150 electrolyte tests per hour, and can host up to 17 onboard tests. Its continuous, random access operation allows labs to run individual tests, panels or profiles and offers STAT capability.
Launched overseas in late 2006, the cobas c 111 system is designed to be the new gold standard for testing in satellite and low-volume labs, and brings innovation to that somewhat under-served niche, according to Dr. Ken Dean, Marketing Manager for Roche Diagnostics. “The cobas c 111 system completes Roche Diagnostics’ clinical analyzer portfolio by bringing all of the power and performance of a large lab analyzer down to a desktop. Essentially, this is a COBAS Integra system engineered for smaller labs, and priced at a fraction of the cost. It’s designed to help healthcare professionals improve 17301-37507- the quality of patient care and to help low-volume labs achieve a positive return on their analyzer investment.”
About the cobas(R) brand
Roche Diagnostics established the cobas brand as the umbrella for products used to complete or expand the screening, diagnostic and monitoring applications of the professional laboratory. The cobas brand includes: serum work area with clinical chemistry and immunochemistry, data management and pre-analytical solutions, products for coagulation analysis and urinalysis, instruments for rapid blood and cardiovascular testing and PCR-based applications for virology and women’s health testing.
About Roche and the Roche Diagnostics Division
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Roche is a world leader in diagnostics, the leading supplier of drugs for cancer and transplantation and a market leader in virology. In 2006, sales by the Pharmaceuticals Division totalled 33.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.7 billion Swiss francs. Roche employs roughly 75,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Roche’s Diagnostics Division offers a uniquely broad product portfolio and supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories worldwide. For further information, please visit our website www.roche-diagnostics.us.
COBAS, COBAS INTEGRA and COBAS C are trademarks of Roche. For further information please contact: Lori McLaughlin Corporate Communications Phone: 317-521-3112 e.mail: lori.mclaughlin@roche.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20070913/CLTH028AP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comRoche Diagnostics
CONTACT: Lori McLaughlin of Corporate Communications, +1-317-521-3112,lori.mclaughlin@roche.com, for Roche Diagnostics
Web site: http://www.roche.com/
